Skip to main content
User account menu
  • Site Staff Website Access Request Form
  • Quick Links
  • Connect With Us
  • Log in
Home
Main navigation
  • About BMT CTN
    • What We Do
    • Why We Do What We Do
    • Who’s Involved
    • BMT CTN Clinical Centers
    • Enrollment in BMT CTN Studies
    • Our Annual Progress Report
    • Publications
    • State of the Science Symposia
    • Our History
    • Study Summaries for Patients
  • BMT CTN Studies
  • Patient & Caregivers
    • Welcome Patients & Caregivers
    • Questions to Ask
    • Enrolling BMT CTN Studies
    • Find BMT CTN Study Results
    • Additional Resources
    • Submit Feedback
    • About Us
  • Investigator & Research Staff Resources
    • Overview
    • Administrative Manual of Procedures (MOP)/Technical Guidelines
    • Center Membership & Study Participation
    • Next Generation Scholar Program
    • Proposals for Clinical Trials & Ancillary Studies
    • Resources for Research Coordinators
    • Funding Opportunities
    • Technical and Administrative Committees
    • Author Resources
  • Partner With Us

BMT CTN Studies Page

BMT CTN 0101_Fungal_Consents_v7.0

  • Read more about BMT CTN 0101_Fungal_Consents_v7.0

BMT CTN 0101_FAQs

  • Read more about BMT CTN 0101_FAQs

BMT CTN 0101 Protocol

  • Read more about BMT CTN 0101 Protocol

BMT CTN 0101 ICF

  • Read more about BMT CTN 0101 ICF

7_BMT CTN 2001 FAQs v1.0_201019

  • Read more about 7_BMT CTN 2001 FAQs v1.0_201019

2101 Study Plan - Appendices

  • Read more about 2101 Study Plan - Appendices

1904 ICFs

  • Read more about 1904 ICFs

1902 ICF's

  • Read more about 1902 ICF's

1703&Mi-Immune FAQs - Final

  • Read more about 1703&Mi-Immune FAQs - Final

1506_2215-CL-0304_Protocol_v3.0_Final

  • Read more about 1506_2215-CL-0304_Protocol_v3.0_Final

Pagination

  • Previous page ‹‹
  • Page 35
  • Next page ››
Subscribe to BMT CTN Studies Page
Blood & Marrow Transplant Clinical Trials Network (BMT CTN)
Copyright ©, The Emmes Company, LLC
Blood and Marrow Transplant Clinical Trials Network Twitter